Biochemistry (Moscow)

, Volume 84, Issue 7, pp 693–694 | Cite as

Thematic Issue: Immuno-Oncology and Immunotherapy

  • A. A. ZamyatninJr.Email author


Currently, the use of immunotherapeutic approaches for creating new efficient therapeutic agents for cancer treatment is considered as one of the most promising areas in oncology. Despite significant advances in immuno-oncology during the recent years, some unresolved problems remain. The articles included in this thematic issue highlight the topical aspects of cancer immunotherapy by presenting different viewpoints of scientists, physicians, and drug developers.


immunotherapy immuno-oncology anticancer vaccines tumor-associated macrophages 


  1. 1.
    Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W, Gutierrez, C, Locke, F. L., Komanduri, K. V, Lin, Y, Jain, N., Daver, N., Westin, J., Gulbis, A. M., Loghin, M. E, de Groot, J. F., Adkins, S., Davis, S. E., Rezvani, K., Hwu, P., and Shpall, E. J. (2018) Chimeric antigen receptor T-cell therapy — assessment and management of toxicities, Nat. Rev. Clin. Oncol, 15, 47–62, doi: 10.1038/nrclinonc.2017.148.CrossRefGoogle Scholar
  2. 2.
    Pardoll, D. M. (2012) The blockade of immune checkpoints in cancer immunotherapy, Nat. Rev. Cancer, 12, 252–264, doi: 10.1038/nrc3239.CrossRefGoogle Scholar
  3. 3.
    Santos, P. M., and Butterfield, L. H. (2018) Dendritic cell-based cancer vaccines., Immunol., 200, 443–449, doi: 10.4049/jimmunol.l701024.CrossRefGoogle Scholar
  4. 4.
    Caux, C, Ramos, R. N., Prendergast, G. C, Bendriss-Vermare, N., and Menetrier-Caux, C. (2016) A milestone review on how macrophages affect tumor growth, Cancer Res., 76, 6439–6442, doi: 10.1158/0008-5472.CAN-16-2631.CrossRefGoogle Scholar
  5. 5.
    Bravo, I., Sanjose, S., and Gottschling, M. (2010) The clinical importance of understanding the evolution of papilloma viruses, Trends Microbiol., 18, 432–438, doi: 10.1016/j.tim.2010.07.008.CrossRefGoogle Scholar
  6. 6.
    Gershovich, P. M., Karabel’sky A. V, Ulitin, A. B., and Ivanov, R. A. (2019) The role of checkpoint inhibitors and cytokines in adoptive cell-based cancer immunotherapy with genetically modified T cells, Biochemistry (Moscow), 84, 695–710, doi: 10.1134/S0006297919070022.Google Scholar
  7. 7.
    Doronin, A., Gordeev, A., Kozlov, A., Smirnova, Y., Puchkova, M., Ekimova, V, Basovsky Y, and Solov’ev, V. (2019) T-Cell engagers based bioassay for evaluation of PD-1/PD-L1 inhibitors activity, Biochemistry (Moscow), 84, 711–719, doi: 10.1134/ S0006297919070034.Google Scholar
  8. 8.
    Abakushina, E. V, Gel’m, Yu. V, Pasova, I. A., and Bazhin, A. V. (2019) Immunotherapeutic approaches for the treatment of colorectal cancer, Biochemistry (Moscow), 84, 720–728, doi: 10.1134/ S0006297919070046.Google Scholar
  9. 9.
    Kapitanova, K. S., Naumenko, V. A, Garanina, A. S., Melnikov, P. A., Abakumov, M. A, and Alieva, I. B. (2019) Advances and challenges of nanoparticle-based macrophage reprogramming for cancer immunotherapy, Biochemistry (Moscow), 84, 729–745, doi: 10.1134/ S0006297919070058.Google Scholar
  10. 10.
    Petushkova, A. I., Savvateeva, L. V, Korolev, D. O., and Zamyatnin, A. A., Jr. (2019) Cysteine cathepsins: potential applications in diagnostics and therapy of malignant tumors, Biochemistry (Moscow), 84, 746–761, doi: 10.1134/ S000629791907006X.Google Scholar
  11. 11.
    Zav’yalova, M. V, Denisov, E. V, Tashireva, L. A., Savel’eva, O. E., Kaigorodova, E. V, Krahmal’, N. V, and Perel’muter, V. M. (2019) Intravasation as a key step in cancer metastasis, Biochemistry (Moscow), 84, 762–772, doi: 10.1134/S0006297919070071.Google Scholar
  12. 12.
    Syrkina, M. S., and Rubtsov, M. A. (2019) MUCl in cancer immunotherapy — new hope or phantom menace? Biochemistry (Moscow), 84, 773–781, doi: 10.1134/ S0006297919070083.Google Scholar
  13. 13.
    Vonsky M., Shabaeva, M., Runov, A., Palefsky J., and Isaguliants, M. (2019) Carcinogenesis associated with human papillomavirus infection, mechanisms and potential for immunotherapy, Biochemistry (Moscow), 84, 782–799, doi: 10.1134/S0006297919070095.Google Scholar
  14. 14.
    Vonsky, M., Runov, A., Gordeychuk, I., and Isaguliants, M. (2019) Therapeutic vaccines against human papilloma viruses: achievements and prospects, Biochemistry (Moscow), 84, 800–816, doi: 10.1134/S0006297919070101.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2019

Authors and Affiliations

  1. 1.Sechenov First Moscow State Medical UniversityInstitute of Molecular MedicineMoscowRussia
  2. 2.Belozersky Institute of Physico-Chemical BiologyLomonosov Moscow State UniversityMoscowRussia

Personalised recommendations